3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
3
Neoplasms
2
Malignant Solid Neoplasm
2
Lung Neoplasms
2
Breast Neoplasms
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Localized Head and Neck Carcinoma
1
Laryngeal Neoplasms
1
Inflammatory Bowel Diseases
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Depressive Disorder
1
Depression
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Specimen Handling
1
STA 9090
1
SGN-LIV1A
1
Proton Therapy
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.